Results for ''
COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first...
The COALESCE study’s primary aim is to provide both the UK and the devolved governments with the information necessary to actionably improve COVID-19 vaccine uptake and coverage.
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research from HDR UK South-West.
The UK Health Data Research Alliance today welcomes UK Longitudinal Linkage Collaboration (UK LLC) to join the current 71 members who are working collaboratively to help researchers address some...
Research from HDR UK reveals fundamental changes to the spike protein in the Omicron variant that are likely to be important in its rapid global spread
Largest study of body mass index (BMI) and COVID-19 vaccine effectiveness using the QResearch platform suggests two doses are highly effective against severe disease for people who are...
People with longstanding kidney disease face health issues like heart disease and diabetes that could impact their risk of severe COVID-19 and life expectancy, according to a new study enabled by...
A large-scale clinical trial of a monoclonal antibody treatment for COVID-19 showed that it could reduce deaths by 21 per cent in people who had not mounted a natural antibody response of their own.
Study published in The Lancet Digital Health and supported by the BHF Data Science Centre used health data from 57 million people in England to build the most complete picture of the pandemic in a...
